COVID-19 as a Risk Factor for Alzheimer’s Disease
Journal of Alzheimer's Disease · 03.01.2023 · 91 (1) · 1-23
DOI: 10.3233/jad-220800 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 03.01.2023. Verfasst von Mahdieh Golzari-Sorkheh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: COVID-19, Alzheimer Disease, Nervous System Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 255 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease, recent reports indicate that it also affects the central nervous system (CNS). Over 25% of COVID-19 patients report neurological symptoms such as memory loss, anosmia, hyposmia, confusion, and headaches. The neurological outcomes may be a result of viral entry into the CNS and/or resulting neuroinflammation, both of which underlie an elevated risk for Alzheimer’s disease (AD). Herein, we ask: Is COVID-19 a risk factor for AD? To answer, we identify the literature and review mechanisms by which COVID-19-mediated neuroinflammation can contribute to the development of AD, evaluate the effects of acute versus chronic phases of infection, and lastly, discuss potential therapeutics to address the rising rates of COVID-19 neurological sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, University of Toronto, Toronto, ON, Canada.
- Krembil Research Institute, University Health Network, Toronto, ON, Canada.
- Department of Chemistry, University of Toronto, Toronto, ON, Canada.
- Department of Pharmaceutical Chemistry, University of Toronto, Toronto, ON, Canada.
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Zitieren
APA
Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023). COVID-19 as a Risk Factor for Alzheimer’s Disease. Journal of Alzheimer's Disease, 91(1), 1-23. https://doi.org/10.3233/jad-220800
Vancouver
Golzari-Sorkheh M, Weaver DF, Reed MA. COVID-19 as a Risk Factor for Alzheimer’s Disease. Journal of Alzheimer's Disease. 2023;91(1):1-23. doi:10.3233/jad-220800
BibTeX
@article{GolzariSorkheh2023,
author = {Golzari-Sorkheh, Mahdieh and Weaver, Donald F and Reed, Mark A},
title = {COVID-19 as a Risk Factor for Alzheimer’s Disease},
journal = {Journal of Alzheimer's Disease},
year = {2023},
volume = {91},
number = {1},
pages = {1--23},
doi = {10.3233/jad-220800}
}
EUVIMED